WEST PHARMACEUTICAL SERVICES, INC.: net property, plant and equipment
Net property, plant and equipment for WEST PHARMACEUTICAL SERVICES, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All WEST PHARMACEUTICAL SERVICES, INC. financial histories
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2009-12-31 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 1,726,400,000 | USD | 2026-02-17 | 10-K · 0000105770-26-000010 |
| At date | 2024-12-31 | 1,581,600,000 | USD | 2026-02-17 | 10-K · 0000105770-26-000010 |
| At date | 2023-12-31 | 1,413,300,000 | USD | 2025-02-18 | 10-K · 0000105770-25-000013 |
| At date | 2022-12-31 | 1,158,300,000 | USD | 2024-02-20 | 10-K · 0000105770-24-000015 |
| At date | 2021-12-31 | 1,057,500,000 | USD | 2023-02-21 | 10-K · 0000105770-23-000012 |
| At date | 2020-12-31 | 943,200,000 | USD | 2022-02-22 | 10-K · 0001628280-22-003342 |
| At date | 2019-12-31 | 839,300,000 | USD | 2021-02-23 | 10-K · 0000105770-21-000008 |
| At date | 2018-12-31 | 822,000,000 | USD | 2020-02-24 | 10-K · 0000105770-20-000015 |
| At date | 2017-12-31 | 855,000,000 | USD | 2020-02-24 | 10-K · 0000105770-20-000015 |
| At date | 2016-12-31 | 778,300,000 | USD | 2019-02-28 | 10-K · 0000105770-19-000012 |
| At date | 2015-12-31 | 721,000,000 | USD | 2018-02-26 | 10-K · 0000105770-18-000006 |
| At date | 2014-12-31 | 705,800,000 | USD | 2017-02-28 | 10-K · 0000105770-17-000011 |
| At date | 2013-12-31 | 711,700,000 | USD | 2016-02-26 | 10-K · 0000105770-16-000060 |
| At date | 2012-12-31 | 669,000,000 | USD | 2015-02-25 | 10-K · 0000105770-15-000007 |
| At date | 2011-12-31 | 593,600,000 | USD | 2014-02-27 | 10-K · 0000105770-14-000005 |
| At date | 2010-12-31 | 554,800,000 | USD | 2013-02-27 | 10-K · 0000105770-13-000007 |
| At date | 2009-12-31 | 577,100,000 | USD | 2012-03-01 | 10-K/A · 0000105770-12-000013 |
Related financial histories
- WEST PHARMACEUTICAL SERVICES, INC.: total assets
- WEST PHARMACEUTICAL SERVICES, INC.: total liabilities
- WEST PHARMACEUTICAL SERVICES, INC.: stockholders equity
- WEST PHARMACEUTICAL SERVICES, INC.: cash and cash equivalents
- WEST PHARMACEUTICAL SERVICES, INC.: net income or loss
- WEST PHARMACEUTICAL SERVICES, INC.: operating cash flow
- WEST PHARMACEUTICAL SERVICES, INC.: capital expenditure payments
- WEST PHARMACEUTICAL SERVICES, INC.: revenue
- WEST PHARMACEUTICAL SERVICES, INC.: contract revenue excluding tax
- WEST PHARMACEUTICAL SERVICES, INC.: financing cash flow
- WEST PHARMACEUTICAL SERVICES, INC.: investing cash flow
- WEST PHARMACEUTICAL SERVICES, INC.: retained earnings or deficit
- WEST PHARMACEUTICAL SERVICES, INC.: basic weighted-average shares
- WEST PHARMACEUTICAL SERVICES, INC.: diluted weighted-average shares
- WEST PHARMACEUTICAL SERVICES, INC.: basic earnings per share
- WEST PHARMACEUTICAL SERVICES, INC.: diluted earnings per share
- WEST PHARMACEUTICAL SERVICES, INC.: income tax expense or benefit
- WEST PHARMACEUTICAL SERVICES, INC.: share-based compensation expense
- WEST PHARMACEUTICAL SERVICES, INC.: operating income or loss
- WEST PHARMACEUTICAL SERVICES, INC.: current assets
- WEST PHARMACEUTICAL SERVICES, INC.: interest expense
- WEST PHARMACEUTICAL SERVICES, INC.: current liabilities
- WEST PHARMACEUTICAL SERVICES, INC.: current accounts payable
- WEST PHARMACEUTICAL SERVICES, INC.: goodwill carrying amount
- WEST PHARMACEUTICAL SERVICES, INC.: net finite-lived intangible assets
- WEST PHARMACEUTICAL SERVICES, INC.: net current accounts receivable
- WEST PHARMACEUTICAL SERVICES, INC.: common-stock repurchase payments
- WEST PHARMACEUTICAL SERVICES, INC.: net inventory
- WEST PHARMACEUTICAL SERVICES, INC.: gross profit
- WEST PHARMACEUTICAL SERVICES, INC.: selling, general and administrative expense
- WEST PHARMACEUTICAL SERVICES, INC.: research and development expense
Inspect the source
- Entity
- WEST PHARMACEUTICAL SERVICES, INC. / CIK 0000105770
- Captured
- 2026-09-19T14:54:38.433Z
- SEC response SHA-256
c3a7f52d8bbdb9a06145973d83c1f4190a4d6619d572e4e3ede7677b74c530b5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000105770.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))